| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 36,409 | 124,983 | 86,465 | | Cost of Revenue | 13,974 | 18,143 | 12,532 | | | Gross Profit | 22,435 | 106,840 | 73,933 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 8,658 | 7,739 | 5,070 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 13,777 | 99,101 | 68,863 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (321,120) | (3,422) |
-
| | Earnings Before Interest And Taxes | 13,777 | 18,076 | 17,013 | | Interest Expense | 7,469 |
-
| 1,350 | | Income Before Tax | 6,309 | 18,076 | 15,662 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (314,811) | 95,679 | 67,513 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (314,811) | 95,679 | 67,513 | | Preferred Stock And Other Adjustments | (1,827) | (24,017) | (10,111) | | | Net Income Applicable To Common Shares | ($316,639) | $71,662 | $57,402 |
|
0.23% Nasdaq 
0.03%
Income Statement
